irAE
根據研究免疫相關不良事件(immune-related adverse events, irAE)主要包括皮疹、肝炎、腹瀉、. 腸胃道副作用、肺炎等，通常可能發生在開始使用. 免疫檢查點抑制劑後數週至3 ... ,2019年9月30日 — 本文將探討ICPi 常見或重要的irAE，以及在發生irAE 時如何處理。 關鍵字：免疫檢查點抑制劑、免疫相關副作用、immune checkpoint inhibitor (ICPi)、 ... ,2018年9月26日 — 雖然免疫相關副作用(irAE) 通常可以用皮質類固醇或其他免疫調節劑來控制，但仍有發生少數致命作用。然而，個別臨床試驗報告無法全面性描述這些少數的 ... ,由 S Das 著作 · 2019 · 被引用 190 次 — Immune-related adverse event (IRAE) onset may represent one such clinical biomarker for ICI response. Across disease sites, patients who ... ,由 HJ Albandar 著作 · 2021 · 被引用 1 次 — The three most common irAEs after the initial rechallenge were thyroid dysfunction, diarrhea/colitis, and rash (Supplemental Table S1). The ...,由 S Das 著作 · 2019 · 被引用 190 次 — One potential clinical biomarker for ICI response in patients is immune-related adverse event (IRAE) onset.IRAEs are thought to represent ... ,由 HJ Albandar 著作 · 2021 · 被引用 1 次 — Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not? ,由 B Shankar 著作 · 2020 · 被引用 26 次 — Objective: To characterize multisystem irAEs, their association with survival, and risk factors for multisystem irAE development. ,由 B El Osta 著作 · 2016 · 被引用 5 次 — Targeting immune checkpoints is a novel and growing strategic approach in cancer therapy. This strategy may trigger irAE. We hypothesize that more patients ... ,由 H Albandar 著作 · 2020 — Immune-related adverse events (irAE) to cancer immune checkpoint inhibitors (CPI) and survival outcomes: To rechallenge or not—An ...
| 相關軟體 Immunet 資訊 | |
|---|---|
 irAE 相關參考資料
免疫檢查點抑制劑之副作用處理 - 彰化基督教醫院藥學部
根據研究免疫相關不良事件(immune-related adverse events, irAE)主要包括皮疹、肝炎、腹瀉、. 腸胃道副作用、肺炎等，通常可能發生在開始使用. 免疫檢查點抑制劑後數週至3 ... http://pharm.cch.org.tw 免疫檢查點抑制劑引起irAE 探討／陳宜正、鄭吉元 ... - 藥學雜誌
2019年9月30日 — 本文將探討ICPi 常見或重要的irAE，以及在發生irAE 時如何處理。 關鍵字：免疫檢查點抑制劑、免疫相關副作用、immune checkpoint inhibitor (ICPi)、 ... https://jtp.taiwan-pharma.org. 期刊導讀：與免疫檢查點抑製劑(Immune Checkpoint Inhibitor ...
2018年9月26日 — 雖然免疫相關副作用(irAE) 通常可以用皮質類固醇或其他免疫調節劑來控制，但仍有發生少數致命作用。然而，個別臨床試驗報告無法全面性描述這些少數的 ... https://unclegene6666.pixnet.n Immune-related adverse events and anti-tumor efficacy of ...
由 S Das 著作 · 2019 · 被引用 190 次 — Immune-related adverse event (IRAE) onset may represent one such clinical biomarker for ICI response. Across disease sites, patients who ... https://jitc.biomedcentral.com Immune-Related Adverse Events (irAE) in ... - NCBI - NIH
由 HJ Albandar 著作 · 2021 · 被引用 1 次 — The three most common irAEs after the initial rechallenge were thyroid dysfunction, diarrhea/colitis, and rash (Supplemental Table S1). The ... https://www.ncbi.nlm.nih.gov Immune-related adverse events and anti-tumor ... - PubMed
由 S Das 著作 · 2019 · 被引用 190 次 — One potential clinical biomarker for ICI response in patients is immune-related adverse event (IRAE) onset.IRAEs are thought to represent ... https://pubmed.ncbi.nlm.nih.go Immune-Related Adverse Events (irAE) in Cancer ... - PubMed
由 HJ Albandar 著作 · 2021 · 被引用 1 次 — Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not? https://pubmed.ncbi.nlm.nih.go Multisystem Immune-Related Adverse Events Associated With ...
由 B Shankar 著作 · 2020 · 被引用 26 次 — Objective: To characterize multisystem irAEs, their association with survival, and risk factors for multisystem irAE development. https://pubmed.ncbi.nlm.nih.go A meta-analysis of immune-related adverse events (irAE) of ...
由 B El Osta 著作 · 2016 · 被引用 5 次 — Targeting immune checkpoints is a novel and growing strategic approach in cancer therapy. This strategy may trigger irAE. We hypothesize that more patients ... https://www.annalsofoncology.o Immune-related adverse events (irAE) to cancer immune ...
由 H Albandar 著作 · 2020 — Immune-related adverse events (irAE) to cancer immune checkpoint inhibitors (CPI) and survival outcomes: To rechallenge or not—An ... https://ascopubs.org |